Caxton Associates »

Syndax Pharmaceuticals shares owned by Caxton Associates

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Caxton Associates from 13F filings

Historical chart of Caxton Associates investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Caxton Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Caxton Associates

Quarter filed Position value Share count Share price at filing
2025-03-31 $257k 21k 12.29

More positions owned by Caxton Associates

Tesla Motors (TSLA)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Intel Corporation (INTC)
Kellogg Company Put Option (K)
Ishares Msci Mexico Etf (EWW)
Uranium Energy (UEC)
Ishares Msci Brazil Etf (EWZ)
Cameco Corporation (CCJ)
Netflix (NFLX)
Frontier Communications Pare (FYBR)
Kraneshares Trust Csi Chi Internet (KWEB)
Sandisk Corp Put Option (SNDK)

View all positions for Caxton Associates

Top funds holding Syndax Pharmaceuticals

BlackRock
Kynam Capital Management
Goldman Sachs Group
Vanguard Group
Point72 Asset Management
State Street Corporation
Eversept Partners
Adage Capital Partners GP
Kingdon Capital Management
Franklin Resources
Geode Capital Management
Soleus Capital Management
UBS Group
Qube Research & Technologies
Catalio Capital Management

View all funds holding Syndax Pharmaceuticals